Preradiation Therapy PSA Is Predictive of Biochemical Progression-free Survival Following Postprostatectomy Salvage Radiation Therapy

被引：0
|
作者：
Shukla, M. E. [1 ]
Mir, M. C. [1 ]
Stephenson, A. J. [1 ]
Stephans, K. L. [1 ]
Klein, E. A. [1 ]
Tendulkar, R. D. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.1067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [21] Progression-Free Survival of Children With Localized Ependymoma Treated With Intensity-Modulated Radiation Therapy or Proton-Beam Radiation Therapy
    Sato, Mariko
    Gunther, Jillian R.
    Mahajan, Anita
    Jo, Eunji
    Paulino, Arnold C.
    Adesina, Adekunle M.
    Jones, Jeremy Y.
    Ketonen, Leena M.
    Su, Jack M.
    Okcu, M. Fatih
    Khatua, Soumen
    Dauser, Robert C.
    Whitehead, William E.
    Weinberg, Jeffrey
    Chintagumpala, Murali M.
    CANCER, 2017, 123 (13) : 2570 - 2578
  • [22] Progression-free survival rates for radical prostatectomy in the PSA era
    Desireddi, VN
    Roehl, KA
    Loeb, S
    Yu, XY
    Griffin, C
    Kundu, S
    Han, M
    Catalona, WJ
    JOURNAL OF UROLOGY, 2006, 175 (04): : 209 - 209
  • [23] PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure
    T T Shah
    M Peters
    A Kanthabalan
    N McCartan
    Y Fatola
    J van der Voort van Zyp
    M van Vulpen
    A Freeman
    C M Moore
    M Arya
    M Emberton
    H U Ahmed
    Prostate Cancer and Prostatic Diseases, 2016, 19 : 311 - 316
  • [24] PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure
    Shah, T. T.
    Peters, M.
    Kanthabalan, A.
    McCartan, N.
    Fatola, Y.
    van Zyp, J. van der Voort
    van Vulpen, M.
    Freeman, A.
    Moore, C. M.
    Arya, M.
    Emberton, M.
    Ahmed, H. U.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (03) : 311 - 316
  • [25] Postprostatectomy salvage radiation therapy for prostate cancer: Impact of pathological and biochemical variables and prostate fossa biopsy
    Mosbacher, MR
    Schiff, PB
    O'Toole, KM
    Benson, MC
    Olsson, CA
    Brody, RA
    Ennis, RD
    CANCER JOURNAL, 2002, 8 (03): : 242 - 246
  • [26] PSA trend before and during salvage radiation therapy: Prognostic factor for biochemical control
    Hannan, R.
    Rossinow, J.
    Chen, Y.
    Kabarri, R.
    Skinner, W.
    Landau, E. M.
    Spierer, M.
    Guha, C.
    Kainicki, S.
    Garg, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Predictive factors for disease progression after salvage radiation therapy in biochemical recurrent patients treated by radical prostatectomy
    Aikawa, Koichi
    Kimura, Shoji
    Urabe, Fumihiko
    Iwatani, Kosuke
    Tashiro, Kojiro
    Ochi, Atsuhiko
    Abe, Hirokazu
    Aoki, Manabu
    Kimura, Takahiro
    PROSTATE INTERNATIONAL, 2023, 11 (03) : 145 - 149
  • [28] Is benefit of maintenance therapy for NSCLC best defined by progression-free survival?
    Reckamp, Karen L.
    LANCET ONCOLOGY, 2012, 13 (05): : 435 - 436
  • [29] PROGRESSION-FREE SURVIVAL OF CHILDREN WITH LOCALIZED EPENDYMOMA TREATED WITH INTENSITY-MODULATED RADIATION THERAPY (IMRT) OR PROTON BEAM RADIATION THERAPY (PBRT)
    Sato, Mariko
    Gunther, Jillian
    Mahajan, Anita
    Jo, Eunji
    Paulino, Arnold
    Adesina, Adekunle
    Jones, Jeremy
    Ketonen, Leena
    Su, Jack
    Okcu, Mehmet
    Khatua, Souman
    Dauser, Robert
    Whitehead, William
    Weinberg, Jeffrey
    Chintagumpala, Murali
    NEURO-ONCOLOGY, 2014, 16 : 121 - 121
  • [30] Radiation therapy's contribution to local control and progression-free survival in patients with aggressive lymphomas.
    Wilder, RB
    Rodriguez, MA
    Tucker, SL
    Ha, CS
    Hess, MA
    Cabanillas, FF
    Cox, JD
    BLOOD, 2000, 96 (11) : 251B - 251B
12345